ArticleBreast cancer (Dove Medical Press)2022

Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial.

Roberta Caputo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.